Gold nanoparticles (AuNPs) functionalized with antibodies have the potential to improve biosensing technology because of the unique optical properties of AuNPs and the specificity of antibody–antigen ...

Experimental studies of antibody adsorption and antigen binding that mimicked pregnancy test immunoassays have been performed using neutron reflectivity studies of a model antibody/antigen system ...

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response rates for patients with blastic plasmacytoid dendritic cell neoplasm ...

Sacituzumab govitecan is an antibody-drug conjugate designed to direct a potent chemotherapy drug into cancer cells by targeting a protein called TROP-2 that is found on triple-negative breast ...

ASCO: Bicara ties antibody to 46% 2-year survival rate for head and neck cancer subset By Gabrielle Masson Jun 1, 2025 3:36pm Bicara Therapeutics ASCO 2025 Merus ASCO ...

We have determined the crystal structure at 2.0 Å resolution of the SRCR domain of Mac-2 ... Antibody-based binding domain fused to TCRγ chain facilitates T cell cytotoxicity for potent ...

The crystal structure of cFSP1 is similar to the structure of hFSP1, and it was solved in complex with CoQ1, ... dried milk for 30 min to 1 h. Membranes were incubated overnight with primary ...

The Crystal is an artifact that recently resurfaced, causing chaos across Atlan with powerful factions vowing to find it first to harness its power. Of course, it falls upon you and other adventurers ...

Navigator is also advancing NAV-242, a next-generation, engineered anti-OX40L/TNFα antibody, with half-life-extension, which has the potential for optimized exposure and dosing profile to provide a ...

Traditional antibodies are large and unstable in the presence of gastrointestinal proteases. Here, we present a strategy to engineer potent, protease-stable single-domain antibodies to enable oral ...

Background: HB0025, developed by Huaota, is a novel anti-PD-L1/VEGF bispecific antibody, with VEGFR1D2 linked at the N-terminal of anti- PD-L1 antibody. Carboplatin and paclitaxel (CP) alone or in ...